Family History of Mental Illness Tied to Aggression in Those With CTE
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Chronic traumatic encephalopathy (CTE) pathology influences the effect of first-degree family history of mental illness (1°FHMI) on aggression among individuals with a history of repetitive exposure to head impacts, according to a study published online Nov. 27 in Neurology.
Madeline Uretsky, from the Boston University Alzheimer's Disease Research Center and Chronic Traumatic Encephalopathy Center, and colleagues conducted a retrospective examination of consecutive, deceased, male brain donors with repetitive impact exposure to assess whether CTE pathology affects the association between 1°FHMI and aggression.
Data were included for 845 brain donors; 69.7 percent had CTE and 45.3 percent had a 1°FHMI. The researchers observed a significant association between 1°FHMI and standardized adult Brown-Goodwin Assessment for Lifetime History of Aggression (BGLHA) scores in those with, but not those without, CTE (β = 0.16 for those with CTE). Among those with CTE, the largest effects were seen for those aged 40 to 59 years (β = 0.64), especially for BGLHA factors of emotional dysregulation/impulsiveness (β = 1.68) and antisocial behavior (β = 1.56).
"In a postmortem sample of male contact sport athletes and military veterans, 1°FHMI was significantly associated with increased aggression on the retrospective, informant-based BGHLA scale among brain donors with CTE, but not among donors without CTE," the authors write. "This relationship was driven by donors with CTE who died between 40 and 59 years."
Several authors disclosed ties to the pharmaceutical and biotechnology industries.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-28 12:00
Read more
- Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications
- FDA Approves Kebilidi (eladocagene exuparvovec-tneq) Gene Therapy for the Treatment of AADC Deficiency
- Winter's Onset Brings Mood Changes to Many Americans, Poll Finds
- Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE
- AHA: Rural-Urban Disparities Persist in Cardiovascular Mortality
- Weight-Loss Drug Zepbound May Lower Heart Failure Deaths
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions